Analysis of the Ki-67 labeling index and p53 expression rate in the present study revealed both were higher in ACCs than BCNs: while only 4 of 27 BCNs had a Ki-67 index > 5%, all ACCs had a Ki-67 index of approximately 20%. This evidence concerns the gene TP53 and nevoid basal cell carcinoma syndrome.